At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major issue is individualising treatment to each patient, as response varies greatly between different patients. The challenge is to understand how and which patients will respond to therapies. New drugs are currently on the horizon, which will offer new and better solutions to patients.
1. What have been the most significant recent developments in the area of DME? (1:02)
2. Discuss the current unmet needs and/or the challenges you face when treating patients with DME. (2:00)
3. What developments are you most excited about in the area of DME over the next few years? (3:20)
Share this Video
Related Videos In Retina/Vitreous
Sunir Garg, Hawaiian Eye 2022: Mask Use and Endophthalmitis
Universal mask use was shown to be effective at reducing incidence of endophthalmitis, according to results of a study presented at Hawaiian Eye 2022. We caught up with Dr Sunir Garg (Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA), who gave us an overview of his retrospective review on mask use and […]
Sunir Garg, Hawaiian Eye 2022: Intravitreal Injections and Endophthalmitis
Universal mask use was shown to be effective at reducing incidence of endophthalmitis, according to results of a study presented at Hawaiian Eye 2022. We had the honour of interviewing Dr Sunir Garg (Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA) about his talk on the causes of endophthalmitis and its relationship […]
J Fernando Arevalo, AAO 2021: Highlights and Future Perspectives
We were honored to have the opportunity to ask J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA) about his highlights from the American Academy of Ophthalmology Virtual Meeting 2021. Speaker Disclosure: J Fernando Arevalo has received consultant and advisor fees from Abbvie, Genentech and Thea Laboratories, patents/royalty from […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!